Lung Cancer Clinical Trial

Pilot Study of Model Based Iterative Reconstruction Using 64-Slice

Summary

This study is being performed to confirm that the new technique, Model-Based Iterative Reconstruction (MBIR) with reduced radiation dose can deliver equivalent image quality for CT scans compared to current techniques (Filtered Back Projection with Adaptive Statistical Iterative Reconstruction (FBP with ASiR) and also to demonstrate that MBIR can improve general image quality characteristics at equivalent radiation dose levels.

View Full Description

Full Description

See brief summary

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Men or Women 30 years of age or older voluntarily willing to sign an informed consent.
Patients indicated for one of the following:

CNS: Known or suspected pathology in the posterior fossa Thorax: Patients referred for staging of a known or suspected lung cancer Abdomen: Patients with acute flank pain and suspected urolithiasis or Abdomen: Patients with a known or suspected focal liver lesion

Exclusion Criteria:

Subjects less than 30 years of age
Pregnant women as confirmed by urine test or current accepted institution standard
If IV contrast is required:
Severe or uncontrolled allergy to iodinated contrast media
Serum creatinine > 1.7 mg/dl or estimated glomerular filtration rate [eGFR] of <60 mg/min as recorded in medical file or by current accepted institution standard
Unable or unwilling to provide written informed consent by self or legal guardian at the time of study enrollment
Unstable physical condition as identified by physician

Study is for people with:

Lung Cancer

Estimated Enrollment:

92

Study ID:

NCT01431378

Recruitment Status:

Terminated

Sponsor:

GE Healthcare

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

Massachusetts General Hospital
Boston Massachusetts, 02114, United States
Duke University Medical Center
Durham North Carolina, 27710, United States
Froedtert Memorial Lutheran Hospital
Miwaukee Wisconsin, 53226, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

92

Study ID:

NCT01431378

Recruitment Status:

Terminated

Sponsor:


GE Healthcare

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider